Variant report
Variant | nsv875788 |
---|---|
Chromosome Location | chr2:212722988-212752193 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:212750930..212753692-chr2:212781524..212783089,2 | MCF-7 | breast: | |
2 | chr2:212721894..212724751-chr2:212727440..212730383,2 | MCF-7 | breast: | |
3 | chr2:212742372..212744206-chr2:213400637..213402216,2 | MCF-7 | breast: | |
4 | chr2:212744009..212744725-chr2:213042131..213043046,2 | MCF-7 | breast: | |
5 | chr2:212721894..212724751-chr2:212727440..212730383,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77854795 | chr2:212732254-212732255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186532746 | chr2:212732286-212732287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201022480 | chr2:212732288-212732289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566609881 | chr2:212732369-212732370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76042725 | chr2:212732416-212732417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34790114 | chr2:212732459-212732460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558645311 | chr2:212732530-212732531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76358006 | chr2:212732535-212732536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79475114 | chr2:212732536-212732537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569185746 | chr2:212732568-212732569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs16847131 | chr2:212732582-212732583 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs563461632 | chr2:212732609-212732610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113055582 | chr2:212732616-212732617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554838498 | chr2:212732624-212732625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574689739 | chr2:212732654-212732655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190470572 | chr2:212732710-212732711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553976956 | chr2:212732712-212732713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577133646 | chr2:212732722-212732723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183011558 | chr2:212732726-212732727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562455218 | chr2:212732732-212732733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11903172 | chr2:212732735-212732736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78374979 | chr2:212732741-212732742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561606879 | chr2:212732778-212732779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532324785 | chr2:212732779-212732780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs16847136 | chr2:212732780-212732781 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs546902912 | chr2:212732797-212732798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532873424 | chr2:212732821-212732822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116387855 | chr2:212732837-212732838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532567358 | chr2:212732842-212732843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551016751 | chr2:212732883-212732884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569293609 | chr2:212732898-212732899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187690770 | chr2:212732911-212732912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372876627 | chr2:212732943-212732944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562965865 | chr2:212732946-212732947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190978270 | chr2:212732947-212732948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568457917 | chr2:212732959-212732960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534053310 | chr2:212732979-212732980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554111548 | chr2:212733012-212733013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577073110 | chr2:212733062-212733063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530490789 | chr2:212733101-212733102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567861840 | chr2:212733114-212733115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556222449 | chr2:212733124-212733125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374298527 | chr2:212733132-212733133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576087840 | chr2:212733146-212733147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs13002674 | chr2:212733164-212733165 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs116653201 | chr2:212733203-212733204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182436717 | chr2:212733257-212733258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142270905 | chr2:212733303-212733304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540475137 | chr2:212733318-212733319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112838479 | chr2:212733338-212733339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212732200-212734200 | Enhancers | HUVEC | blood vessel |
2 | chr2:212732400-212733000 | Enhancers | Osteobl | bone |
3 | chr2:212732400-212733400 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr2:212732600-212733200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr2:212732600-212733400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr2:212732600-212733400 | Enhancers | Placenta Amnion | Placenta Amnion |
7 | chr2:212732600-212733400 | Enhancers | GM12878-XiMat | blood |
8 | chr2:212732600-212733400 | Enhancers | Hela-S3 | cervix |
9 | chr2:212732600-212734400 | Enhancers | Fetal Heart | heart |
10 | chr2:212732800-212733600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr2:212734200-212741800 | Weak transcription | HUVEC | blood vessel |
12 | chr2:212740000-212740600 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr2:212740600-212741800 | Weak transcription | Muscle Satellite Cultured Cells | -- |
14 | chr2:212741800-212742000 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr2:212741800-212742400 | Enhancers | HUVEC | blood vessel |
16 | chr2:212745600-212746000 | Enhancers | H9 Cell Line | embryonic stem cell |
17 | chr2:212745600-212746800 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr2:212745800-212746200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr2:212745800-212746400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
20 | chr2:212746000-212746800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
21 | chr2:212751600-212752600 | Enhancers | Fetal Heart | heart |